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Abstract  
Introduction and objective: Legionella pneumophila, the etiological agent of 
Legionnaires’ disease, is an important cause of both community-acquired and nosocomial 
pneumonia; therefore, rapid diagnosis and early antibiotic treatment of pneumonia are 
required. Urinary antigen testing to detect Legionella antigen has proven to be the most 
powerful diagnostic method. Peptidoglycan-associated lipoprotein (PAL) protein of L. 
pneumophila, as a component of Legionella antigens, will be detected efficiently by the PAL 
antigen capture assay and is considered as useful diagnostic antigen to diagnose Legionella 
infection. Because of the transfer of protein to the periplasmic region of Escherichia coli has 
numerous advantages including separation from cytoplasmic proteins and the concentration 
of recombinant proteins in periplasm, the aim of this study was to produce periplasmic PAL 
protein of L. pneumophila in E. coli.  
Materials and methods: The pal gene of L. pneumophila serogroup 1 was amplified with 
specific primers, cloned and expressed under pelB signal sequence and T7 lac promoter in 
pET26b+ plasmid.  
Results: The cloning was confirmed with digestion and sequencing of recombinant pET-
26b-pal plasmid. The expression of r-PAL protein in cytoplasm and periplasmic space of E. 
coli was approved by SDS-PAGE and western blotting.  
Conclusion: The results of this study demonstrated that the r-PAL protein successfully 
expressed in E. coli.  
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Introduction  
Legionellae are part of the microbial 
community of aquatic ecosystems (natural as 
well as manmade), which explain why 
legionellosis occurs worldwide [1]. Results 
of the studies in Iran showed that Legionella 
pneumophila isolated from different aquatic 
and therapeutic centers [2-4]. L. 
pneumophila, the etiological agent of 
Legionnaires’ disease (LD), is an important 
cause of both community-acquired and 
nosocomial pneumonia infection. LD still 
occurs, both in sporadic and epidemic forms, 
sometimes involving hundreds of deads and 
can cause high morbidity and mortality if 
treated improperly [5,6]. In addition, 
Legionella pneumonia may be severe and is 
potentially fatal in elderly and 
immunocompromised patients, and 
therefore, rapid diagnosis, early antibiotic 
treatment and primary prevention of 
pneumonia are required [7,8]. Over the 
intervening years, Legionella urinary antigen 
detection methods have proven to be the 
most powerful diagnostic methods [9,10]. 
Bacterial lipoproteins that are useful 
diagnostic antigens have been a focus of 
vaccine designs, as they are potent B-cell 
mitogens, immunoadjuvants and can be T-
cells inducers [11-13]. The cell envelope of 
L. pneumophila has several interesting 
antigens, including 19-kDa peptidoglycan-
associated lipoprotein (PAL) protein. The 
PAL protein is an immunodominant 
component of Legionella antigens and is a 
highly conserved antigen among Legionella 
species. This supports the idea that it could 
be used as a potential urinary antigen to 
diagnose LD and also as sub-unit vaccine 
against Legionella infections in humans. The 
PAL protein excretes in urine as a general 
component of Legionella antigens and could 
be used as an alternative diagnostic urinary 
antigen [14]. 
Escherichia coli is the best characterized 
and most widely used bacterial host for the 
production of recombinant proteins. E. coli 
expression systems imply a rapid generation 
of biomass, low-cost culture conditions, and 
are very versatile, due to the availability of 
an increasingly large number of cloning 
vectors and host strains. However, most 
recombinant proteins applied in therapy and 
diagnosis are secreted proteins, and will 
form inclusion bodies when expressed in the 
cytoplasm of E. coli. Inclusion bodies are 
formed during cytoplasmic expression of 
recombinant proteins are insoluble protein 
deposits which demand isolation, 
solubilization and proper refolding [15,16]. 
To avoid problems associated with 
cytoplasmic expression; the aim of this study 
was periplasmic expression of r-PAL protein 
in E. coli. 
 
Materials and methods 
Bacterial strains, plasmid, media, and 
culture conditions  
Legionella pneumophila serogroup 1 
(ATCC33152); obtained from the 
American Type Culture Collection 
(ATCC), Manassas, VA was cultured on 
nonselective buffered charcoal-yeast 
extract medium supplemented with 0.1% α-
ketoglutarate (BCYEα medium) and 
selective modified Wadowsky-Yee 
medium (MWY) (Oxoid) [17] at 37ºC and 
5%CO2. E. coli strains were cultured on 
Luria-Bertani (LB) medium (Himedia), 
supplemented with kanamycin (50mg/L), if 
necessary. E. coli strain DH5α and E. coli 
strain BL21 (DE3) (Novagen Inc., 
Madison, Wis.) were used for cloning and 
expression, respectively; and the 
expression vector pET26b+ (Novagen Inc.) 
was used for cloning the PCR products and 
also as the T7-based expression vector. All 
chemicals used in this study were from 
Merck (Germany) and all of the enzymes 
from Roche (Germany), Fermentas 
(Lithuania) or Cinagen (Iran) Companies. 
 
General DNA procedures 
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The genomic DNA of L. pneumophila and 
the pET26b+ plasmid were extracted using 
Genomic DNA Purification and Gene JET 
Plasmid Mini prep Kits, respectively, 
according to the manufacturer’s instructions 
(Fermentas, Lithuania). PCR primers were 
designed based on the full protein-coding 
region of the L. pneumophila pal gene 
(Accession No. X60543) of the 19-kDa 
lipoprotein [18] by the DNASIS v2.6 
Primer Designer Software.  
The forward primer, pal-F, (5'-
CATGCCATGGCAAAAGCCGGATCGT
TTTATAAA-3') contained NcoI recognit-
ion site and reverse primer, pal-R, (5'-
CCCAAGCTTGGGTCTTGTTGCCTCAT
AAATAAAC-3') contained recognition site 
for HindIII. PCR was performed on a 
Termocycler TC-512 (Techne) using 
Expand High Fidelity PCR System (Roche) 
and the PCR fragment was analyzed on a 
1% agarose gel. For purification purposes, 
DNA was extracted from the PCR reaction 
mixture by DNA Extraction Kit (Fermentas, 
Lithuania). 
 
Construction of pET26b-pal expression 
vector 
To form the over-expression pET26b-pal 
plasmid, the PCR product and the pET26b+ 
plasmid were digested by NcoI and HindIII 
restriction enzymes (Fermentas). After NcoI 
and HindIII thermal inactivation, the 
linearized plasmid and the digested PCR 
product were used for ligation by T4 DNA 
ligase (Fermentas). After ligation, E. coli 
DH5α were transformed with the 
recombinant pET26b-pal plasmid and 
selected on LB agar plates containing 
kanamycin (50mg/L). A number of colonies 
were assayed by colony PCR. After 
selecting the recombinant clones, the 
plasmid DNA was extracted from the 
overnight culture and confirmed by 
restriction digestion with KspAI restriction 
enzyme and sequence analysis (TAG 
Copenhagen, Denmark). In order to raise 
protein expression, the recombinant 
pET26b-pal plasmid was transformed into 
competent E. coli BL21 (DE3) cells [19]. 
 
Expression of recombinant PAL protein 
A single colony of E. coli BL21 (DE3) 
carrying the pET26b-pal was used to 
inoculate culture of LB broth supplemented 
with kanamycin (50mg/L) (LBB-K). The 
culture was incubated overnight at 37°C 
with orbital shaking at 250rpm. The 
overnight culture was inoculated to fresh 
LBB-K in a 1:100 volumetric ratio and was 
placed at 37°C with orbital shaking at 250 
rpm. The r-PAL protein expression was 
induced by adding various concentrations 
(0.1-1 mM) of Isopropyl-β-D-
thiogalactopyranoside (IPTG) at an OD600 
of 0.4-1. To determine the time course of 
the r-PAL protein expression, aliquots (1ml) 
of the different cultures were removed just 
before IPTG induction and at different 
times after induction (1, 2, 4, 6, 8, 10, 12, 
and 15 hrs) and subjected for protein 
analysis.  
 
Preparation of the periplasmic extract 
All of the following steps were performed 
at 4°C. The bacterial cells were harvested 
by centrifugation at 5000g and the pellet 
was re-suspended in 100ml TES buffer 
(0.02M Tris-Cl, 0.5M EDTA, and 20% 
sucrose, pH=8.0) per liter of culture. 
Lysozyme (final concentration 1mg/ml, 
Boehringer Germany) and one tablet of 
complete protease inhibitor cocktail 
(Roche) were added to the cell suspension, 
followed by adding 200ml of ice cold 
deionized water. The suspension was 
agitated at 60rpm on ice for 1h and the cells 
were centrifuged at 16000g for 20 minutes. 
Both the pellet as the cytoplasmic and 
membrane fractions and the supernatant, 
which constituted the periplasmic fraction, 
saved for further protein analysis. 
 
SDS-PAGE and Western blotting 
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SDS-PAGE was carried out according to 
the method of Laemmli [20]. The prepared 
protein samples were subjected to 
electrophoresis on 18% polyacrylamide gel 
and stained by Coomassie Blue. To perform 
western blot analysis, proteins were 
transferred from SDS-PAGE gel to a 
0.45µm pore nitrocellulose membrane 
(Amersham Pharmacia Biotech, UK) at 300 
mA for 1.5hrs in Tris-glycine buffer (0.025 
M Tris, 0.2M glycine (pH=8.3) with 20% 
methanol) [21].  
The blotted membrane was blocked in 
fresh TBS blocking buffer (50mM Tris, 
150mM NaCl, pH=7.5) containing 1% 
bovine serum albumin (BSA) at room 
temperature for 1h. Expression of the r-PAL 
protein was monitored by immunodetection 
with mouse anti-His6-peroxidase (Roche), 
using the manufacturer's protocol; the 
membrane probed with anti-His6-peroxidase 
(1:10000 dilution) in TBS blocking buffer 
containing 1% BSA at room temperature for 
1.5hrs. Following three times washing with 
TBST (TBS with 0.1% Tween 20), for five 
minutes; to visualize the r-PAL protein 
band, the membrane was incubated with the 
precipitating substrate solution (BM Blue 




The pal gene of L. pneumophila was 
amplified using specific primers and 
showed a band about 0.55 kb on agarose gel 
(Fig. 1). In order to periplasmic expression 
of the r-PAL protein, the full protein-coding 
region of the pal gene was inserted between 
the NcoI and HindIII restriction sites of the 
pET26b+ plasmid. This resulted in a 
recombinant plasmid pET26b-pal that 
contained the desired pal gene sequence. 
Following the transformation and plating of 
the bacterial cells on LB agar containing 
kanamycin (50mg/L), the transformed 
colonies and the extracted recombinant 
pET26b-pal plasmids were PCR positive 
against the pal gene specific primers. The 
presence of the pal gene in the pET26b-pal 
plasmid was confirmed by digestion with 
KspAI restriction enzyme. The pET26b-pal 
plasmid has two KspAI restriction sites (RS) 
in its sequences; the first in the pET26b+ 
plasmid and the second in the pal gene 
sequence. Therefore, digestion of the 
pET26b-pal plasmid using KspAI restriction 
enzyme produced two expected fragments, 
a 4188 bp and a 1616 bp fragment. 
Digestion results showed the pal gene had 
been inserted in the pET26b+ plasmid (Fig. 
2). Sequencing analysis of the constructed 
plasmid also confirmed that there were no 
amplification errors in sequence of the 
cloned pal gene. 
In order to examine the expression of 
the r-PAL protein, a single colony of E. coli 
BL21 (DE3) carrying the pET26b-pal 
plasmid was cultured and induced with 
IPTG for various post induction durations 
and its cytoplasmic as well as periplasmic 
proteins were subjected to protein analysis. 
SDS-PAGE analysis showed a protein band 
about 21 kDa; however no band detected in 
non-induced culture. This band observed in 
both cytoplasmic and periplasmic fraction 
of extracted total soluble protein (Fig. 3). 
Western blotting analysis was carried out 
for the cytoplasmic and periplasmic 
fractions and the presence of the r-PAL 
protein in E. coli BL21 (DE3) was detected 
(Fig. 4). The results obtained from 
optimization conditions showed the highest 
expression of the r-PAL protein was 
induced by the addition of 1mM IPTG 
induction for 15hrs.  
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Fig. 1: Agarose gel electrophoresis of the amplified pal 
gene by PCR. Lane 1, 0.55kb PCR product; Lane 2, 







Fig. 2: Restriction enzyme analyses of pET26b-pal plasmid and pET26b+ plasmid without 
insert by KspAI restriction enzyme and comparison of digested and purified patterns of 
pET26b+ plasmid and the pal gene PCR product with undigested patterns. Lane 1, the 
pET26b-pal plasmid digested by KspAI (4188bp and 1616bp fragments); Lane 2, undigested 
pET26b-pal plasmid; Lane 3, the pET26b+ plasmid digested by KspAI; Lane 4, undigested 
pET26b+ plasmid; Lane 5 Lambda DNA/EcoRI+HindIII Marker; lane 6, digested and 
purified pET26b+ plasmid (by NcoI and HindIII); Lane 7, undigested pET26b+ plasmid; 
Lane 8, digested and purified PCR product (by NcoI and HindIII); Lane 9, 0.55kb PCR 
product 
1 2 3 4 5 6 7 8 9
564  bp  
1584  bp 
4268  bp 
564  bp  
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Fig. 3: The protein pattern of recombinant bacteria carrying the pET26b-pal plasmid 
demonstrated by SDS-PAGE. IPTG-induced r-PAL protein is marked with arrows. Lane 1, 
PageRuler™ Prestained Protein Ladder; Lane, 2 the cytoplasmic proteins pattern before 
induction; Lane 3, the cytoplasmic proteins pattern 15 hrs after induction and Lane 4, the 
periplasmic proteins pattern 
 
 
Fig. 4: The protein pattern of recombinant bacteria carrying the pET26b-pal plasmid 
demonstrated by western blotting analysis. Lane 1, PageRuler™ Prestained Protein Ladder; 
Lane 2, the cytoplasmic proteins pattern before induction; Lane 3, the cytoplasmic proteins 
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Discussion 
Legionnaires’ disease is a common form of 
severe pneumonia, but these infections are 
infrequently diagnosed [1]. However, urine 
antigen testing has revolutionized the 
laboratory diagnosis of LD, making it the 
most common laboratory test ordered for 
diagnosis of this disease [6]. Several 
research groups have studied the 
characterization of different antigens of L. 
pneumophila in bacterial cells [18,22-25]. 
Here we reported the expression of pal 
gene that is the most prominent surface 
antigen of L. pneumophila [18], which can 
be used subsequently in diagnostic and 
vaccine studies. In this study, we used E. 
coli system for expression of the L. 
pneumophila r-PAL protein because of 
having many advantages like the short 
generation time, the ease of handling, the 
high capacity to accumulate foreign 
proteins, etc. Meanwhile, some 
disadvantages like the lack of 
posttranslational modification has limited 
using this expression system. To overcome 
this problem, we expressed the r-PAL 
protein of L. pneumophila in periplasmic 
space of E. coli.  
The periplasmic expression causes 
some posttranslational modification events 
which can not be done in cytoplasmic 
expression [26,27]. In addition, secretion of 
recombinant proteins to the periplasm of E. 
coli has several advantages over 
intracellular production among which are 
separation from cytoplasmic proteins, 
enhanced biological activity, enhanced 
product solubility and the ease of protein 
purification [28,29]. There is one report on 
the cytoplasmic expression of the L. 
pneumophila pal gene [24]. However, there 
is no report on the periplasmic expression 
of this protein.  
The pET26b+ plasmid was used in this 
study for overexpression of the r-PAL 
protein. The pET26b+ plasmid carried an 
N-terminal pelB signal sequence for 
periplasmic expression and a C-terminal 
His-tag sequence for detection of r-PAL 
protein in binding assays. The His-tag 
generally has no significant effect on the 
structure of the native protein and facilitates 
selective binding of the expressed protein to 
a nickel affinity column [30]. The pET 
expression system is the most powerful 
system and became of this, it is chosen for 
the cloning and expression of recombinant 
proteins in E. coli. The target pal gene 
cloned and drived under the 
transcriptional/translational control of 
strong bacteriophage T7 signals; expression 
was induced by providing a source of T7 
RNA polymerase in the E. coli BL21host 
cell with an advantage that when fully 
induced, almost all of the cell’s resources 
are converted to target gene expression and 
the desired product can comprise main part 
of the total cell protein within 15 hrs after 
induction with 1mM IPTG. 
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